Itemaren erregistro erraza erakusten du

dc.contributor.authorArana Urbieta, Lide
dc.contributor.authorBayón Cordero, Laura
dc.contributor.authorSarasola Telleria, Laura Isabel
dc.contributor.authorBerasategi, Miren
dc.contributor.authorRuiz, Sandra
dc.contributor.authorAlcorta Calvo, Miren Itziar
dc.date.accessioned2019-05-09T08:21:19Z
dc.date.available2019-05-09T08:21:19Z
dc.date.issued2019-03-20
dc.identifier.citationNanomaterials 9(3) : (2019) // Article ID 464es_ES
dc.identifier.issn2079-4991
dc.identifier.urihttp://hdl.handle.net/10810/32715
dc.description.abstractSolid lipid nanoparticles (SLN) present low toxicity, versatility to incorporate both lipophilic and hydrophilic drugs, controlled drug release and they are easy to scale-up. It is well known that the endocytosis pathway by which SLN are taken up and the subsequent subcellular distribution are crucial for the biological effect of the incorporated drug. In addition, interactions between SLN and cells depend on many factors, such as, the composition of nanoparticle surface. In this work different amounts of phosphatidylethanolamine polyethylene glycol (PE-PEG) were added to SLN composed of stearic acid, Epikuron 200 and sodium taurodeoxycholate. Characterization of obtained nanoparticle suspensions were performed by the analysis of particle size, polydispersity index, zeta-potential, cell toxicity and cell internalization pathway. We have observed that the presence of PE-PEG improves active cell internalization of the nanoparticles in an oral adenocarcinoma cell line, reducing non-specific internalization mechanisms. Finally, we have tested the effect of surface coating on the efficiency of incorporated drugs using all-trans retinoic acid as a model drug. We have observed that delivery of this drug into PE-PEG coated SLN increases its chemotoxic effect compared to non-coated SLN. Therefore, it can be concluded that surface modification with PE-PEG improves the efficiency and the specificity of the SLN-loaded drug.es_ES
dc.description.sponsorshipThis work was supported by grant ELKARTEK (2017) KK-2017/00008.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectsolid lipid nanoparticleses_ES
dc.subjectphosphatidilethanolamine-polyethileneglycoles_ES
dc.subjectcontrolled drug deliveryes_ES
dc.subjectcell internalization pathwayes_ES
dc.subjectcytotoxicityes_ES
dc.subjectall-trans retinoic acides_ES
dc.subjectdrug-deliveryes_ES
dc.subjectretinoic acides_ES
dc.subjectgene deliveryes_ES
dc.subjecttransporterses_ES
dc.subjectendocytosises_ES
dc.subjectformulationes_ES
dc.subjectmechanismes_ES
dc.subjectreceptores_ES
dc.subjectbindinges_ES
dc.titleSolid Lipid Nanoparticles Surface Modification Modulates Cell Internalization and Improves Chemotoxic Treatment in an Oral Carcinoma Cell Linees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.mdpi.com/2079-4991/9/3/464es_ES
dc.identifier.doi10.3390/nano9030464
dc.departamentoesBioquímica y biología moleculares_ES
dc.departamentoeuBiokimika eta biologia molekularraes_ES


Item honetako fitxategiak

Thumbnail
Thumbnail

Item hau honako bilduma honetan/hauetan agertzen da

Itemaren erregistro erraza erakusten du

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Bestelakorik adierazi ezean, itemaren baimena horrela deskribatzen da:This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).